AT390135T
Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
Abstract
Claimed is treatment, preventing and/or control myelodysplasia syndrome method. The specific method comprises, alone or with the second active ingredients, wherein and/or the blood or the transplanting with an of the adjusting immunity compounds or wherein the pharmaceutically acceptable salt, solvate, hydrate, the stereomeride and compound or; the medicine. The special second active ingredients can affect the hemopoiesis. The claimed is suitable for pharmaceutical composition, the sole unit dosage-form and medicament for box of the method of the invention is.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
65 members in 20 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 41846802 | United States of America | P |
Members65
| Document | Office | Kind | |
|---|---|---|---|
| CA2477301A1 | Canada | A1 | |
| WO2004035064A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003228508A1 | Australia | A1 | |
| US2004220144A1 | United States of America | A1 | |
| EP1487461A1 | European Patent Office (EPO) | A1 | |
| KR20050053769A | Republic of Korea | A | |
| MXPA05003888A | Mexico | A | |
| BR0315315A | Brazil | A | |
| EP1487461A4 | European Patent Office (EPO) | A4 | |
| HK1073427A1 | Hong Kong, China | A1 | |
| CN1713917A | China | A | |
| JP2006507271A | Japan | A | |
| ZA200503025B | South Africa | B | |
| KR20070020141A | Republic of Korea | A | |
| JP2007045839A | Japan | A | |
| US7189740B2 | United States of America | B2 | |
| KR100711181B1 | Republic of Korea | B1 | |
| US2007196330A1 | United States of America | A1 | |
| EP1900369A1 | European Patent Office (EPO) | A1 | |
| EP1487461B1 | European Patent Office (EPO) | B1 | |
| NZ539533A | New Zealand | A | |
| NZ552052A | New Zealand | A | |
| AT390135TThis record | Austria | T | |
| DE60319967D1 | Germany | D1 | |
| US7393863B2 | United States of America | B2 | |
| AU2008202638A1 | Australia | A1 | |
| US2008161360A1 | United States of America | A1 | |
| PT1487461E | Portugal | E | |
| DK1487461T3 | Denmark | T3 | |
| SI1487461T1 | Slovenia | T1 | |
| ES2304509T3 | Spain | T3 | |
| AU2003228508B2 | Australia | B2 | |
| DE60319967T2 | Germany | T2 | |
| CA2477301C | Canada | C | |
| CN101564390A | China | A | |
| CN100579527C | China | C | |
| IL168061A | Israel | A | |
| JP4481828B2 | Japan | B2 | |
| US2010278779A1 | United States of America | A1 | |
| US7863297B2 | United States of America | B2 | |
| US2011172273A1 | United States of America | A1 | |
| WO2011143147A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2008202638B2 | Australia | B2 | |
| AU2012201727A1 | Australia | A1 | |
| AU2011253161A1 | Australia | A1 | |
| EP2568983A1 | European Patent Office (EPO) | A1 | |
| US8404716B2 | United States of America | B2 | |
| US8404717B2 | United States of America | B2 | |
| CN103025330A | China | A | |
| JP2013526525A | Japan | A | |
| US2013202590A1 | United States of America | A1 | |
| AU2012201727B2 | Australia | B2 | |
| AU2014202561A1 | Australia | A1 | |
| AU2011253161B2 | Australia | B2 | |
| US2015038444A1 | United States of America | A1 | |
| US9056120B2 | United States of America | B2 | |
| AU2014202561B2 | Australia | B2 | |
| BRPI0315315B1 | Brazil | B1 | |
| EP3219317A1 | European Patent Office (EPO) | A1 | |
| US9925207B2 | United States of America | B2 | |
| US2018207185A1 | United States of America | A1 | |
| MX358515B | Mexico | B | |
| US2019269712A1 | United States of America | A1 | |
| BRPI0315315B8 | Brazil | B8 | |
| US11116782B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 3726262
Titles2
- German
- VERFAHREN ZUR VERWENDUNG VON UND ZUSAMMENSETZUNGEN MIT IMMUNOMODULATORISCHEN VERBINDUNGEN ZUR BEHANDLUNG UND VERSORGUNG VON MYELODYSPLASTISCHEN SYNDROMEN
- English
- METHOD FOR THE USE OF COMPOUNDS AND COMPOUNDS WITH IMMUNOMODULATIVE COMPOUNDS FOR THE TREATMENT AND SUPPLY OF MYELODYSPLASTIC SYNDROMES
Classification
- CPC, 9
- A61K31/496
- A61K31/454
- A61K31/724
- A61P7/00
- A61P7/06
- A61P35/02
- A61P37/00
- A61P37/02
- A61P43/00
- IPC, 4
- A61K31 454
- A61K31 496
- A61K31 724
- A61P7 06